Cantel Medical Reports Financial Results For the Second Quarter Ended January 31, 2017
Cantel Medical reported GAAP net income of $18,070,000, or $0.43 per diluted share, on a 16.8% increase in sales to $184,817,000 for the second quarter ended January 31, 2017. This compares with net income of $15,389,000, or $0.37 per diluted share, on sales of $158,271,000 for the second quarter ended January 31, 2016.
Cantel Medical to Expand Direct Sales Operations in Australia
Cantel Medical announced that it entered into a definitive agreement to purchase its endoscopy business assets from Australian distributor, CR Kennedy & Company Pty Ltd.
President and CEO Jorgen B. Hansen Rings NYSE opening bell
Company celebrates 20th year of leadership in infection prevention.
CANTEL Acquires Endoscopy Assets from Vantage Endoscopy
The Company has expanded its direct sales operations in Canada by acquiring endoscope reprocessing business assets from its Canadian distributor, Vantage Endoscopy, Inc., a subsidiary of Diploma Canada Holdings Ltd.